Christopher McNulty

Christopher McNulty

Director of Finance/CFO chez Ring Therapeutics, Inc.

Fortune : 743 $ au 31/03/2024

47 ans
Health Technology
Electronic Technology
Finance

Profil

Christopher McNulty is currently the Chief Financial Officer & Head-Corporate Strategy at Ring Therapeutics, Inc. He previously worked as the Senior Director-Business Development at Repligen Corp.
from 2010 to 2013, Associate Director-Business Development at Genzyme Corp.
in 2008-2009, Director-Corporate Development at YourBio Health, Inc. in 2009-2010, and Chief Financial & Accounting Officer at Invivo Therapeutics Holdings Corp.
from 2017 to 2018.
He also held various Principal positions at Ionis Pharmaceuticals, Inc., PTC Therapeutics, Inc., Cereon Genomics LLC, and Hewlett-Packard Laboratories.
McNulty's education includes an undergraduate and graduate degree from Massachusetts Institute of Technology and an MBA degree from Harvard Business School.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
26/01/2023 1 233 ( 0,01% ) 743 $ 31/03/2024

Postes actifs de Christopher McNulty

SociétésPosteDébut
Director of Finance/CFO 01/05/2023
Tous les postes actifs de Christopher McNulty

Anciens postes connus de Christopher McNulty

SociétésPosteFin
VBI VACCINES INC. Director of Finance/CFO 10/04/2023
INVIVO THERAPEUTICS HOLDINGS CORP. Director of Finance/CFO 01/05/2018
REPLIGEN CORPORATION Corporate Officer/Principal 01/11/2013
Corporate Officer/Principal 01/04/2010
Corporate Officer/Principal 01/03/2009
Voir l'expérience en détail de Christopher McNulty

Formation de Christopher McNulty

Massachusetts Institute of Technology Graduate Degree
Harvard Business School Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Christopher McNulty

Relations

52

Relations au 1er degré

13

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées5
REPLIGEN CORPORATION

Health Technology

IONIS PHARMACEUTICALS, INC.

Health Technology

PTC THERAPEUTICS, INC.

Health Technology

INVIVO THERAPEUTICS HOLDINGS CORP.

Health Technology

VBI VACCINES INC.

Health Technology

Entreprise privées6

Health Technology

Electronic Technology

Health Technology

Cereon Genomics LLC

Hewlett-Packard Laboratories

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Christopher McNulty